Rovida Investment Management Ltd Has $246.19 Million Stock Position in Nebius Group N.V. $NBIS

Key Points

• Rovida Investment Management boosted its stake in Nebius by 26% to 2,193,647 shares worth $246.19 million, making NBIS the firm's largest holding at 27.9% of its portfolio (≈0.93% of Nebius outstanding).
• Nebius secured local approval for a 1.2‑GW, 400‑acre AI factory campus in Independence, Missouri with Chapter 100 incentives and community commitments, a cornerstone project management says is critical to meeting contracted capacity and growth targets.
• The company missed recent quarterly EPS and revenue estimates (reported ($0.69) vs. ($0.42) expected; $227.7M revenue vs. $246.05M consensus) and trades with a negative P/E and high volatility, prompting valuation and execution concerns despite strong analyst interest.

Rovida Investment Management Ltd boosted its position in Nebius Group N.V. (NASDAQ:NBIS - Free Report) by 26.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,193,647 shares of the company's stock after buying an additional 453,000 shares during the period. Nebius Group makes up 27.9% of Rovida Investment Management Ltd's holdings, making the stock its biggest holding. Rovida Investment Management Ltd owned about 0.93% of Nebius Group worth $246,193,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of NBIS. Trek Financial LLC bought a new stake in Nebius Group in the third quarter worth approximately $2,309,000. J.W. Cole Advisors Inc. grew its position in shares of Nebius Group by 123.9% during the 3rd quarter. J.W. Cole Advisors Inc. now owns 33,488 shares of the company's stock worth $3,760,000 after buying an additional 18,533 shares during the period. Invesco Ltd. increased its stake in shares of Nebius Group by 2.7% in the 2nd quarter. Invesco Ltd. now owns 3,587,811 shares of the company's stock valued at $198,514,000 after acquiring an additional 92,710 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Nebius Group by 297.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 848,336 shares of the company's stock valued at $46,938,000 after acquiring an additional 634,838 shares in the last quarter. Finally, Salem Investment Counselors Inc. lifted its position in shares of Nebius Group by 2,272.7% during the 3rd quarter. Salem Investment Counselors Inc. now owns 26,930 shares of the company's stock valued at $3,023,000 after acquiring an additional 25,795 shares during the period. 21.90% of the stock is currently owned by institutional investors and hedge funds.

Nebius Group Stock Performance

Shares of NBIS opened at $95.65 on Friday. The firm has a market capitalization of $24.09 billion, a P/E ratio of -65.51 and a beta of 4.02. Nebius Group N.V. has a 52 week low of $18.31 and a 52 week high of $141.10. The stock has a 50 day moving average price of $95.14 and a two-hundred day moving average price of $96.69. The company has a debt-to-equity ratio of 0.89, a quick ratio of 6.57 and a current ratio of 3.08.

Nebius Group (NASDAQ:NBIS - Get Free Report) last posted its earnings results on Thursday, February 12th. The company reported ($0.69) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.27). Nebius Group had a net margin of 19.02% and a negative return on equity of 11.70%. The company had revenue of $227.70 million during the quarter, compared to the consensus estimate of $246.05 million. Equities analysts forecast that Nebius Group N.V. will post -1.1 earnings per share for the current fiscal year.

Trending Headlines about Nebius Group

Here are the key news stories impacting Nebius Group this week:

• Positive Sentiment: Secured local approval for a 1.2‑GW, 400‑acre AI factory campus in Independence, Missouri — a cornerstone project that materially expands Nebius’s capacity and gives the company a visible runway to capture strong AI infrastructure demand. Nebius Secures Approval for Its First Gigawatt-Scale AI Factory
• Positive Sentiment: Approval comes with Chapter 100 incentives and community commitments (jobs, education programs), reducing project political and permitting risk and making the build-out more likely to proceed on the proposed timeline. Nebius Group Wins Approval For US AI Campus With Community Focus
• Positive Sentiment: Company narrative validated: capacity is already highly contracted/sold out and management has public ARR and growth targets — the Missouri project is presented as critical to hitting those targets, which underpins the bullish case. Nebius' 1.2 GW Win: A $20B Bet on AI Infrastructure
• Neutral Sentiment: Sector tailwinds: rising demand for AI inference/training capacity (examples: CoreWeave partnering with Perplexity on GB200 clusters) supports long‑term demand for third‑party data center capacity. This broadly benefits Nebius if execution follows. Will Perplexity's AI Workloads Accelerate CRWV's Next Leg of Expansion?
• Neutral Sentiment: Multiple bullish write-ups and interviews (MarketBeat, 247WallSt, Motley/Fool coverage) have amplified investor interest — helpful for momentum but increases the importance of execution milestones. Nebius Group Just Became a Major AI Infrastructure Player
• Negative Sentiment: Valuation concerns: several pieces question whether today's price already discounts the upside — articles flag high multiples (sales multiple and stretched P/E metrics) and ask if it's too late to buy after the recent run. As Nebius Gets the Green Light for a Massive AI Factory, Should You Buy NBIS Stock?
• Negative Sentiment: Short‑term volatility and profit‑taking: after the approval-driven surge, analysts and screens show a pullback and rapid re‑rating — investors are focusing on execution timing, multi‑billion-dollar capex needs and how much is truly funded. Nebius Stock Jumps 10% After Securing Massive U.S. AI Campus Approval

Analyst Upgrades and Downgrades

A number of research firms have commented on NBIS. BWS Financial restated a "buy" rating and issued a $130.00 price target on shares of Nebius Group in a report on Tuesday, February 17th. Northland Securities raised their target price on Nebius Group from $206.00 to $211.00 and gave the company an "outperform" rating in a research note on Wednesday, November 12th. Freedom Capital raised Nebius Group to a "strong-buy" rating in a research note on Tuesday, February 3rd. Morgan Stanley began coverage on Nebius Group in a report on Thursday, January 15th. They issued an "equal weight" rating and a $126.00 price target on the stock. Finally, Compass Point started coverage on Nebius Group in a report on Wednesday, February 18th. They set a "buy" rating and a $150.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $143.22.

Nebius Group Profile

Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company's services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability.

Want to see what other hedge funds are holding NBIS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nebius Group N.V. (NASDAQ:NBIS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.